Hepatopulmonary Syndrome Markedly Increases Mortality in Cirrhotic Patients
Algolia Search
Schedule Telemedicine Consult with Dr. Gish Powered byTelemed2U
Powered byTelemed2U

Hepatopulmonary Syndrome Markedly Increases Mortality in Cirrhotic Patients

Hepatopulmonary Syndrome (HPS) is a serious vascular complication of liver disease that markedly increases mortality. The median survival time in cirrhotic patients with HPS is ~ 10.6 months compared to 40.8 months in cirrhotic patients without HPS.

https://jumpshare.com/v/6Gmg5gIvxodJulbQ5pAk